Business & Finance
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
29 September 2025 - Danish biotechnology company Genmab A/S (CPH:GMAB) announced on Monday that it has agreed to acquire clinical-stage oncology company Merus N.V. (Nasdaq:MRUS) in an all-cash transac...
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
...
Abbott announces quarterly common dividend
22 September 2025 - Global healthcare company Abbott (NYSE:ABT) announced on Friday a quarterly dividend of USD0.59 per share of common stock.This amount is unchanged from the previous quarterly divid...
CVS Health declares unchanged quarterly dividend
18 September 2025 - US healthcare company CVS Health (NYSE:CVS) announced on Wednesday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per shar...
ALK partners with GenSci to expand allergy immunotherapy market in China
17 September 2025 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) said on Wednesday that it has agreed a partnership with Chinese biopharmaceutical company Changchun GeneScienc...
Curatis secures Swiss distribution deal with Phoenix Labs
5 September 2025 - Swiss pharmaceutical company Curatis Holding AG (SIX:CURN) announced on Friday that it has signed a distribution agreement with healthcare company Phoenix Labs (Ireland) covering fo...